US20050053958A1 - Methods for identifying risk of breast cancer and treatments thereof - Google Patents

Methods for identifying risk of breast cancer and treatments thereof Download PDF

Info

Publication number
US20050053958A1
US20050053958A1 US10/723,142 US72314203A US2005053958A1 US 20050053958 A1 US20050053958 A1 US 20050053958A1 US 72314203 A US72314203 A US 72314203A US 2005053958 A1 US2005053958 A1 US 2005053958A1
Authority
US
United States
Prior art keywords
nucleotide sequence
breast cancer
1b
1a
figs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/723,142
Inventor
Richard Roth
Matthew Nelson
Stefan Kammerer
Andreas Braun
Rikard Reneland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sequenom Inc
Original Assignee
Sequenom Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US42913602P priority Critical
Priority to US49023403P priority
Application filed by Sequenom Inc filed Critical Sequenom Inc
Priority to US10/723,142 priority patent/US20050053958A1/en
Assigned to SEQUENOM, INC. reassignment SEQUENOM, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ROTH, RICHARD B., RENELAND, RIKARD HENRY, BRAUN, ANDREAS, KAMMERER, STEFAN M., NELSON, MATTHEW ROBERTS
Publication of US20050053958A1 publication Critical patent/US20050053958A1/en
Application status is Abandoned legal-status Critical

Links